1-15 of 15
Keywords: Statins
Close
Sort by
Journal Articles
Journal Articles
Journal: Cardiology
Cardiology (2022) 147 (5-6): 497–506.
Published Online: 04 October 2022
... effects of statin therapy differ between patients with low prolactin production and patients with normal levels of this hormone. Methods: We studied two groups of cabergoline-treated premenopausal women with hypercholesterolemia matched for age, plasma lipids, cabergoline dose, and treatment duration: 11...
Journal Articles
Journal: Cardiology
Cardiology (2020) 145 (6): 375–383.
Published Online: 14 April 2020
...Tasnim Imran; Adrian Wong; Sebastian Schneeweiss; Rishi J. Desai Background: To compare the risk of incident heart failure (HF) between initiators of hydrophilic and lipophilic statins. Methods: Using claims data for commercial health insurance program enrollees in the USA (2005–2014), we...
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Journal: Cardiology
Cardiology (2014) 128 (4): 327–332.
Published Online: 17 June 2014
... metalloproteinases Statins Since its discovery, aortic aneurysm disease has been nothing but a black cloud for those afflicted with the disease, the number of whom has been steadily increasing over the past decades. In 2007, aortic aneurysms accounted for 12,986 deaths in the US, making aneurysm the 19th...
Journal Articles
Journal Articles
Journal: Cardiology
Cardiology (2013) 124 (2): 105–107.
Published Online: 07 February 2013
...James J. DiNicolantonio; Victor L. Serebruany Context: Much emphasis has been placed on a ticagrelor-aspirin (ASA) interaction in the Platelet Inhibition and Patient Outcomes (PLATO) trial, despite this particular interaction being inconclusive. However, a potential ticagrelor-statin interplay...
Journal Articles
Journal: Cardiology
Cardiology (2008) 112 (1): 4–12.
Published Online: 25 June 2008
...Steven M. Shaw; James E. Fildes; Nizar Yonan; Simon G. Williams HMG-CoA (3-hydroxy-3-methylglutaryl coenzyme A) reductase inhibitors, or ‘statins’, have revolutionized the management of patients with atherosclerotic vascular disease. Following 2 large acute coronary syndrome trials, additional...
Journal Articles
Journal Articles
Journal Articles
Journal: Cardiology
Cardiology (2002) 97 (3): 115–121.
Published Online: 12 June 2002
...Antonio Muscari; Giovanni M. Puddu; Paolo Puddu Most of the currently available statins and fibric acid derivatives have been implicated in causing complications either in monotherapy or in combination therapy. Adverse events occur more often with the statins that are metabolized via the CYP enzyme...
Journal Articles
Journal: Cardiology
Cardiology (2001) 95 (1): 9–13.
Published Online: 25 May 2001
... of cardiovascular disease through abnormalities in the production, release or degradation of endothelium-derived factors, mainly nitric oxide and endothelin 1. Several reports have shown that drugs of the statin class could have multiple beneficial effects related to endothelium-mediated vasoactive, antithrombotic...